Claims
- 1. The dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole or a pharmaceutically acceptable non-toxic acid addition salt thereof.
- 2. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in free form.
- 3. A compound as claimed in claim 1 being the dextrorotory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of a pharmaceutically acceptable salt with an inorganic or organic acid.
- 4. A compound as claimed in claim 1 being the dextrorotory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of the hydrochloric acid salt, the hydrobromic acid salt, the sulphuric acid salt or the phosphoric acid salt.
- 5. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of a salt with D-tartaric acid or L-tartaric acid or in the form of an O,O'-diacyl derivative of the same derived from benzoic acid optionally substituted by C.sub.1 -C.sub.4 -alkyl, C.sub.1 -C.sub.4 -alkoxy, halogen of an atomic number of up to and including 35 and/or nitro.
- 6. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of the salt with acetic acid, propionic acid, succinic acid, glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, ascorbic acid, maleic acid, phenylacetic acid, benzoic acid, 4-aminobenzoic acid, anthranilic acid, 4-hydroxybenzoic acid, salicylic acid, aminosalicylic acid, embonic acid or nicotinic acid, or alternatively with methanesulphonic acid, ethanesulphonic acid, 2-hydroxyethanesulphonic acid, ethylenesulphonic acid, benzenesulphonic acid, p-toluenesulphonic acid, naphthalenesulphonic acid, sulphanilic acid or cyclohexylsulphamic acid.
- 7. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of the L-tartrate.
- 8. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form the di-p-toluoyl-D-tartrate.
- 9. A compound as claimed in claim 1 being the dextrorotatory enantiomer of trans-5,6-di-p-methoxyphenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole in the form of the di-p-toluene-L-tartrate.
- 10. A pharmaceutical preparation having anti-inflammatory and anti-rheumatic action comprising a therapeautically effective amount of a compound of claim 1 and customary pharmaceutical auxiliaries and carriers.
Priority Claims (1)
Number |
Date |
Country |
Kind |
87/79 |
Jan 1979 |
CHX |
|
Parent Case Info
This is a continuation of application Ser. No. 108,904 filed on Dec. 31, 1979, now abandoned.
US Referenced Citations (8)
Non-Patent Literature Citations (1)
Entry |
C.A. vol. 72, 12645/p (1970). |
Continuations (1)
|
Number |
Date |
Country |
Parent |
108904 |
Dec 1979 |
|